SPONSOR
IRCCS Ospedale San Raffaele
Total Trials
2
Recruiting
2
Phases
Phase 2
IRCCS Ospedale San Raffaele is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including VHL - Von Hippel-Lindau Syndrome, Ulcerative Colitis (UC), Crohn Disease (CD).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — IRCCS Ospedale San Raffaele
How many clinical trials has IRCCS Ospedale San Raffaele sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by IRCCS Ospedale San Raffaele, of which 2 are actively recruiting participants. These trials cover conditions including VHL - Von Hippel-Lindau Syndrome, Ulcerative Colitis (UC), Crohn Disease (CD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does IRCCS Ospedale San Raffaele research focus on?
IRCCS Ospedale San Raffaele clinical trials span VHL - Von Hippel-Lindau Syndrome, Ulcerative Colitis (UC), Crohn Disease (CD). The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a IRCCS Ospedale San Raffaele clinical trial?
To participate in a IRCCS Ospedale San Raffaele trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all IRCCS Ospedale San Raffaele trials with current recruitment status updated daily.
Clinical Trials by IRCCS Ospedale San Raffaele
NCT07171905 Phase 2
Recruiting
CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease
VHL - Von Hippel-Lindau Syndrome
NCT06896305
Recruiting
Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
Ulcerative Colitis (UC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology